Ulcerative Colitis News

Ozanimod Results Promising in Crohn's Disease, Ulcerative Colitis, Phase 2 Trial Data Show - IBD News Today



IBD News Today
 
Ozanimod Results Promising in Crohn's Disease, Ulcerative Colitis, Phase 2 Trial Data Show 
IBD News Today
Celgene recently presented positive data from two Phase 2 studies ? the STEPSTONE and TOUCHSTONE studies ? for the company's investigational compound ozanimod (RPC-1063) as a therapy for Crohn's disease and ulcerative colitis at the World ...
Celgene Abandons Crohn's Drug; Could Others Take Its Spot? Investor's Business Daily
Celgene dives 10% after ditching key drug MarketWatch
Why Celgene Corporation Dropped Today Madison.com
Healio  -Endpoints News  -Business Insider 
all 56 news articles » 


Ozanimod Shows Potential for Crohn's Disease, Ulcerative Colitis - Specialty Pharmacy Times (blog)



IBD News Today
 
Ozanimod Shows Potential for Crohn's Disease, Ulcerative Colitis 
Specialty Pharmacy Times (blog)
Celgene Corporation recently announced that data from a phase 2 clinical trial exploring ozanimod in Crohn's disease (CD) and ulcerative colitis (UC) will be ...
IBD Therapy Entyvio Eased Ulcerative Colitis, Crohn's, Analysis ... IBD News Today

all 2 news articles » 


Ulcerative Colitis - Pipeline Review, H2 2017 - PR Newswire (press release)



Ulcerative Colitis - Pipeline Review, H2 2017 
PR Newswire (press release)
Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory Bowel Disease (IBD). The disease is characterized by open sores and ulcers in the colon. The risk factors for UC include ...

and more » 


Study finds more patients with ulcerative colitis but less number of ... - News-Medical.net



News-Medical.net
 
Study finds more patients with ulcerative colitis but less number of ... 
News-Medical.net
Today, a higher number of patients with ulcerative colitis are able to keep their bowel and steer clear of surgery, as shown in a study from örebro University.

and more » 


Seres plots ulcerative colitis trial drive after posting 1b data - FierceBiotech



FierceBiotech
 
Seres plots ulcerative colitis trial drive after posting 1b data 
FierceBiotech
Seres Therapeutics has posted top-line data from a phase 1b of SER-287 in ulcerative colitis. The microbiome pioneer thinks the data support the rapid advance of SER-287 deeper into the clinic, although question marks about the results mean that doubts ...
Microbiome therapy shows benefit in ulcerative colitis Healio
Seres' SER-287 for UC Shows Positive Results in Phase 1b Trial IBD News Today
Seres Therapeutics (MCRB) Says It's 'Extremely Pleased' with Topline Results from SER-287 Phase 1b Study in ... StreetInsider.com
Madison.com 
all 33 news articles » 


What's the Difference in IBD and IBS? Part One of a Series - IBD News Today



IBD News Today
 
What's the Difference in IBD and IBS? Part One of a Series 
IBD News Today
Editor's note: This is the first installment in a series of columns about the similarities and the differences among IBD, Crohn's, colitis, IBS and celiac disease. Inflammatory bowel diseases like Crohn's, ulcerative colitis (UC) and the other ...
Gut Health May Begin in the Mouth Harvard Magazine
Evidence found of oral bacteria contributing to bowel disorders Medical Xpress

all 4 news articles » 


Ulcerative Colitis Market Absolute Analysis & Worldwide Foresight to 2022 - Digital Journal



Ulcerative Colitis Market Absolute Analysis & Worldwide Foresight to 2022 
Digital Journal
Pune, India -- (SBWIRE) -- 10/20/2017 -- Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum part of human body. Inflammation and ulcers are formed in the innermost lining of the colon and rectum ...

and more » 


France Is First EU Country to Give Abivax Go-ahead to Test ABX464 in Ulcerative Colitis - IBD News Today



IBD News Today
 
France Is First EU Country to Give Abivax Go-ahead to Test ABX464 in Ulcerative Colitis 
IBD News Today
France has become the first European country to give Abivax a green light to start clinical trials of ABX464 as a treatment for moderate-to-severe active ulcerative colitis. The therapy candidate is already being tested against HIV/AIDS. Belgium, Czech ...

 


Living With Ulcerative Colitis While at College - IBD News Today



Living With Ulcerative Colitis While at College 
IBD News Today
Emily was diagnosed with ulcerative colitis when she was a freshman in college. The diagnosis itself is stressful enough, but when you're living in shared accommodation and have to share a bathroom with 30 other people, things can get a little bit tricky.

 


Response to Novel Immune Therapy for Ulcerative Colitis ... - GlobeNewswire (press release)



IBD News Today
 
Response to Novel Immune Therapy for Ulcerative Colitis ... 
GlobeNewswire (press release)
VANCOUVER, British Columbia , Oct. 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific ...
7 Things Not to Say to People With Crohn's Disease or Ulcerative ... IBD News Today

all 3 news articles »